Dr. Federico Lavorini embarked on his academic journey in Pistoia, Italy, attending Classic High School “N. Forteguerri” from 1979 to 1984 🏫. He continued his pursuit of knowledge at the University of Florence, graduating with honors from the School of Medicine and Surgery in 1991 🎓. Driven by a passion for respiratory health, he further specialized in Pulmonary Disease, completing the Postgraduate School at the University of Florence from 1992 to 1996 🫁. His academic prowess culminated in a Ph.D. in Applied Pathophysiology, awarded by the University of Florence in the years 1996-2000 🧪. These formative years laid the foundation for Dr. Lavorini’s distinguished career in respiratory medicine and research.
🔍 Research Focus:
Dr. Lavorini’s research is centered around:
Diagnostics and therapeutics of inhaled drugs, emphasizing novel drug delivery methods for managing asthma and COPD. Intractable cough diagnosis and treatment, evaluating cough motor components and sensitivity in patients with respiratory and non-respiratory diseases. Asthma, focusing on controlling breathing and assessing lung function in patients, along with methods to aid correct inhaler usage.
👩💼 Professional Journey:
Consultant in Respiratory Medicine, Careggi University Hospital, Florence (2000-2018). Professor of Respiratory Medicine, University of Florence (2018-). Head of Respiratory Unit, Careggi University Hospital, Florence (2018-).
🏆 Honors & Awards:
Board certified in Pulmonary Disease (1996).
Ph.D. in Applied Pathophysiology (2000).
Co-Chair of the European Respiratory Society/International Society in Aerosol Medicine Guidelines on inhalation devices for asthma and COPD treatment (2018).
📚 Top Noted Publications :
Effect of Incorrect Use of Dry Powder Inhalers on Management of Patients with Asthma and COPD
Authors: F Lavorini, A Magnan, JC Dubus, T Voshaar, L Corbetta, M Broeders, …
Journal: Respiratory Medicine
Year of Publish: 2008
Citation: 102(4), 593-604
Index: 814
Impaired Immune Cell Cytotoxicity in Severe COVID-19 is IL-6 Dependent
Authors: A Mazzoni, L Salvati, L Maggi, M Capone, A Vanni, M Spinicci, …
Journal: The Journal of Clinical Investigation
Year of Publish: 2020
Citation: 130(9), 4694-4703
Index: 490
Critical Inhaler Errors in Asthma and COPD: A Systematic Review of Impact on Health Outcomes
Authors: OS Usmani, F Lavorini, J Marshall, WCN Dunlop, L Heron, E Farrington, …
Journal: Respiratory Research
Year of Publish: 2018
Citation: 19, 1-20
Index: 360
Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes
Authors: DB Price, M Román-Rodríguez, RB McQueen, S Bosnic-Anticevich, …
Journal: The Journal of Allergy and Clinical Immunology: In Practice
Year of Publish: 2017
Citation: 5(4), 1071-1081. e9
Index: 359
The First Tissue-Engineered Airway Transplantation: 5-Year Follow-up Results
Authors: A Gonfiotti, MO Jaus, D Barale, S Baiguera, C Comin, F Lavorini, …
Journal: The Lancet
Year of Publish: 2014
Citation: 383(9913), 238-244
Index: 345
Retail Sales of Inhalation Devices in European Countries: So Much for a Global Policy
Authors: F Lavorini, CJ Corrigan, PJ Barnes, PRN Dekhuijzen, ML Levy, …
Journal: Respiratory Medicine
Year of Publish: 2017
Citation: 105(7), 1099-1103
📊 Author Metrics:
Member of editorial boards for journals like Canadian Respiratory Journal, Journal of Aerosol Medicine, and more.
Member of international research groups, including the Respiratory Effectiveness Group (REG) and the European Respiratory Society.
📅 Research Timeline:
1980s-1990s: Student internships and early clinical exposure at the University of Florence.
2000s: Transitioned into a consultant role, initiated research in diagnostics and therapeutics of inhaled drugs.
2010s: Advanced to Head of Respiratory Unit, expanded research into cough and asthma control.
2018+: Established as a Professor of Respiratory Medicine, leading international guidelines on inhalation devices.